Novel HSP90 inhibitors, NVP-AUY922 and NVP-BEP800, radiosensitise tumour cells through cell-cycle impairment, increased DNA damage and repair protraction

BACKGROUND: Heat-shock protein 90 (Hsp90) has a crucial role in both the stabilisation and regulation of various proteins, including those related to radioresistance. Inhibition of Hsp90 may therefore provide a strategy for enhancing the radiosensitivity of tumour cells. This study explores the resp...

Descripción completa

Detalles Bibliográficos
Autores principales: Stingl, L, Stühmer, T, Chatterjee, M, Jensen, M R, Flentje, M, Djuzenova, C S
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2010
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2883148/
https://www.ncbi.nlm.nih.gov/pubmed/20502461
http://dx.doi.org/10.1038/sj.bjc.6605683

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2883148/
https://www.ncbi.nlm.nih.gov/pubmed/20502461
http://dx.doi.org/10.1038/sj.bjc.6605683

Ejemplares similares